February 07, 2011
More than one-third of 93,000 Medicare managed care enrollees who received care for rheumatoid arthritis in recent years did not receive recommended drugs, according to researchers. In addition, the quality of drug treatments varied among geographic areas, socio-economic groups and health plans. Study results appeared in Wednesday's issue of the Journal of the American Medical Association.